Send your comments and tips to email@example.com
Beth Israel Deaconess Medical Ctr.
Boston Medical Center
Brigham and Women's Hospital
Cambridge Health Alliance
Caritas St. Elizabeth's Medical Ctr.
Children's Hospital Boston
Dana-Farber Cancer Institute
Joslin Diabetes Center
Mass. General Hospital
Mass. Health Law
New England Baptist Hospital
Short White Coat
Tufts-New England Medical Center
UMass Memorial Medical Center
University of Massachusetts
VA Medical Centers
A Healthy Blog
Running A Hospital
Nature Network Boston
SciBos - Corie Lok's blog
Nurse at small
Dr. Gwenn Is In
Healthy Children blog
Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
Short White Coat blogger Ishani Ganguli
Short White Coat blogger Jennifer Srygley
Friday, June 15, 2007
Today's Globe: birds, Lyme cases, diet pill, teen obesity surgery, stem cell bill
The loss of millions of acres of grasslands and shrubs nationwide to suburban sprawl and agriculture -- along with a warming planet -- has dramatically reduced the numbers of common birds (including the grackle, left) seen across the United States over the past 40 years, according to a National Audubon Society study released yesterday.
The number of Lyme disease cases reported in Massachusetts jumped by about 50 percent from 2004 to 2005, a single-year increase that prompted concerned state health officials to say they were stepping up efforts to educate the public about prevention of the disease.
Eager dieters snapped up all the packages of alli at dozens of Walgreen Co. stores yesterday, providing a sneak peek at how the nation's only federally approved over-the-counter diet pill would be greeted today, the first day of nationwide sales.
Adolescents are less likely to suffer complications from obesity surgery than adults, a reassuring finding because little had been known about the risk facing the small but growing number of teens who opt for it, researchers said yesterday.
As the bill to allow federally funded stem cell research heads to the White House, the question is not whether research on embryonic stem cells will go forward, Ellen Goodman writes on the op-ed page. It is going forward in foreign countries and private companies and states that support it from Massachusetts to California. It's whether it will go forward with federal funding and oversight and accountability.